SEC Form 4 · accession 0001213900-18-011407
IMMUCELL CORP /DE/ · ICCC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Scott Tomsche
Director
Period of report
Aug 16, 2018
Accepted (ET)
Aug 20, 2018 · 10:26 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811641
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.10 per shareF1 | Aug 16, 2018 | P | 3,000 | $6.67 | A | 75,789 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1(1) This figure includes 2,322 shares of common stock held by immediate family members of Dr. Tomsche.